RespireRx Pharmaceuticals Inc. - FORM 10-K - EX-23.1 - CONSENT OF HASKELL & WHITE LLP - April 8, 2010

Attached files

file filename
10-K - FORM 10-K - RespireRx Pharmaceuticals Inc.d10k.htm
EX-32 - CERTIFICATION BY CEO AND CFO - SECTION 906 - RespireRx Pharmaceuticals Inc.dex32.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - RespireRx Pharmaceuticals Inc.dex21.htm
EX-31.2 - CERTIFICATION BY CFO - SECTION 302 - RespireRx Pharmaceuticals Inc.dex312.htm
EX-31.1 - CERTIFICATION BY CEO - SECTION 302 - RespireRx Pharmaceuticals Inc.dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (No. 333-161143, No. 333-155749, No. 333-138844, No. 333-122026, No. 333-112043, and No. 333-108948) on Form S-3 of Cortex Pharmaceuticals, Inc. and in the related Prospectus and in the Registration Statements (No. 333-143374, No. 333-134490, No. 333-102042, No. 333-82477, and No. 333-20777) on Form S-8 and pertaining to the 2006 and 1996 Stock Incentive Plans, the Mark A. Varney Non-Qualified Stock Option Agreement dated January 30, 2006 and the Leslie Street Non-Qualified Stock Option Agreement dated March 5, 2007, the 1989 Incentive Stock Option, Nonqualified Stock Option and Stock Purchase Plan, the 1989 Special Nonqualified Stock Option and Stock Purchase Plan, and the Executive Stock Plan, of Cortex Pharmaceuticals, Inc. of our report dated April 7, 2010, with respect to the financial statements of Cortex Pharmaceuticals, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2009.

 

/s/ Haskell & White LLP
HASKELL & WHITE LLP

Irvine, California

April 7, 2010

RespireRx Pharmaceuticals Inc. Reports